SIU 2017: Are We Subjecting Too Many Patients to an Early Re-Resection?

Lisbon, Portugal (  Early TURBT re-resection is recommended for incomplete primary resections, large or multiple tumours, the presence of high-grade disease, or the absence of muscle in the specimen. Current evidence in high-grade disease shows residual disease in 33-53%, with upstaging to muscle-invasive disease in 4-25%. The objective of the authors in this study was to investigate patients diagnosed with high-grade bladder cancer with muscle in the specimen, and assess if they may benefit more from commencing intravesical BCG over early re-resection.

In this study, 94 patients were found to have high-grade disease on their first resection between January 2014 and July 2016. Retrospective data was collected on initial resection, re-resection, and treatment.

Forty three patients (46%) had muscle in their first resection. Twenty two patients (23%) had concomitant carcinoma-in-situ. Seventy seven patients (82%) had an early re-resection. Four patients (4.3%) were upstaged to muscle invasive bladder cancer; 2 had concomitant carcinoma-in-situ and lacked muscle in the first resection, 1 lacked muscle, and 1 had an incomplete resection. Forty patients (52%) had residual tumour on re-resection. Eight out of seventeen patients had no residual disease when muscle was in the primary resection and re-resection was completed within 8 weeks compared with 11/22 when muscle was present and re-resection was delayed beyond 8 weeks.

The authors conclude that in their center under-staging was rare. Therefore, the authors suggest that not all patients require an early re-resection. Further sub-classification of high-grade disease based upon multi-disciplinary discussion of operative and histological findings would enable optimisation of treatment in this group of patients.

Presented by: Brophy T. 
Affiliation: Royal Preston Hospital, Preston, United Kingdom

Written by: Hanan Goldberg, MD, Urologic Oncology Fellow (SUO), University of Toronto, Princess Margaret Cancer Centre.Twitter: @GoldbergHanan at the 37th Congress of Société Internationale d’Urologie - October 19-22, 2017- Lisbon, Portugal

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.